- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: HER2-ve metastatic breast cancer
Total 89845 results
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationSpain, United States, Korea, Republic of, Taiwan, Italy, Australia, France
-
SOLTI Breast Cancer Research GroupNovartis; Alliance Foundation Trials, LLC.RecruitingMetastatic Breast CancerUnited States, Spain, Portugal
-
AstraZenecaEnrolling by invitationBreast Cancer | Ovarian CancerItaly, Spain, United States, Canada, Belgium, Denmark, Korea, Republic of, Czechia, Turkey, China, United Kingdom, Taiwan, Brazil, Israel, France, Hungary, Poland, Portugal, Germany, Russian Federation, Bulgaria, Finland, Slovenia, Sw...
-
US Oncology ResearchAbbVie; Pharmacyclics LLC.Active, not recruitingBreast Neoplasms | Malignant Neoplasm of BreastUnited States
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | Breast Neoplasm | Carcinoma, Ductal, BreastUnited Kingdom, Bulgaria, Georgia, Moldova, Republic of
-
AstraZenecaCompletedHER2-ve Metastatic Breast Cancer | Germline BRCA1/2 Mutations | Somatic BRCA1/2 MutationsItaly, Spain, Poland, Taiwan, Canada, France, Germany, Korea, Republic of, Hungary, Japan, Russian Federation, Turkey, United Kingdom, United States, Bulgaria
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Stage IV Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer FemaleUnited States, Belgium, Bulgaria, Georgia, Netherlands, Moldova, Republic of, Ukraine
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastSpain, United States, Argentina, Austria, Italy, Russian Federation, Thailand, Brazil, Peru, Philippines, Hong Kong, Mexico
-
AstraZenecaQuintiles; University of Tubingen - GermanyCompletedBreast CancerUnited States, Bulgaria, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Canada, Poland, Australia, Hungary, Taiwan, Japan, Germany, United Kingdom
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, United Kingdom, France, United States, Denmark, Hong Kong
-
Merck Sharp & Dohme LLCNot yet recruiting
-
University of Southern CaliforniaNational Cancer Institute (NCI)Not yet recruitingMalignant Solid Neoplasm | Breast Carcinoma | Metastatic Prostate Carcinoma | Ovarian Carcinoma | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Pancreatic Exocrine Neoplasm | Stage IVB Prostate Cancer American Joint Committee on Cancer v8United States
-
Biotheus Inc.Not yet recruitingTriple Negative Breast Cancer(TNBC)China
-
Pravin T.P KaumayaNot yet recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoma | EGFR OverexpressionUnited States
-
AstraZenecaNot yet recruitingMetastatic Breast CancerBrazil
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
M.D. Anderson Cancer CenterNot yet recruitingHormone Receptor-positive Human Epidermal Growth Factor 2-negative | Metastatic Invasive LObular CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingMetastatic Breast CancerUnited States
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Not yet recruitingMetastatic Breast Cancer | Stage IV Breast Cancer AJCC V7
-
Institut Claudius RegaudFondation Toulouse Cancer SantéNot yet recruitingMetastatic Breast CancerFrance
-
Centre Antoine LacassagneThuasneRecruitingNon-metastatic Breast CancerFrance
-
858 Therapeutics, Inc.RecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Advanced or Metastatic Solid Tumors | ER+ Breast Cancer | Castrate Resistant Prostate Cancer | BRCA MutationUnited States
-
Fudan UniversityRecruitingTNBC - Triple-Negative Breast CancerChina
-
Mayo ClinicRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | Hormone-receptor-positive Breast CancerUnited States
-
AstraZenecaDaiichi SankyoNot yet recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerCanada
-
Shanghai Escugen Biotechnology Co., LtdNot yet recruitingMetastatic Breast CancerChina
-
Sun Yat-sen UniversityNot yet recruitingBreast Cancer | Ipsilateral Supraclavicular Lymph Node Metastasis
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not yet recruiting
-
Institut de cancérologie Strasbourg EuropeContinuum Plus Santé; Plateforme nationale qualité de vie et cancer; WeShareRecruitingBreast Neoplasms | Lung Neoplasms | Prostatic Neoplasms | Colorectal NeoplasmsFrance
-
American Society of Clinical OncologyPatient-Centered Outcomes Research InstituteNot yet recruitingMetastatic Breast Cancer
-
Washington University School of MedicineUnited States Department of Defense; Aclaris Therapeutics, Inc.Not yet recruitingHormone Receptor Positive HER-2 Negative Metastatic Breast CancerUnited States
-
ABSCINT NV/SANot yet recruiting
-
Wuhan Union Hospital, ChinaRecruitingTriple-negative Breast Cancer | CadonilimabChina
-
Puma Biotechnology, Inc.Not yet recruitingMetastatic Breast Cancer | Recurrent Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Universitaire Ziekenhuizen KU LeuvenEli Lilly and Company; Kom Op Tegen Kanker; Teva PharmaRecruitingTriple Negative Breast NeoplasmsBelgium
-
Fudan UniversityRecruiting
-
Filipa Lynce, MDMerck Sharp & Dohme LLC; Zentalis PharmaceuticalsNot yet recruitingBreast Cancer | Triple Negative Breast Cancer | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor Negative Malignant Tumor Breast TripleUnited States
-
Centro di Riferimento Oncologico - AvianoNot yet recruiting
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not yet recruiting
-
Aarhus University HospitalDanish Cancer SocietyRecruitingMetastatic Breast Cancer | Adiposity | Estrogen-receptor-positive Breast CancerDenmark
-
Fudan UniversityRecruiting
-
Fudan UniversityRecruiting
-
European Institute of OncologyRecruitingMetastatic Breast CancerItaly
-
The Netherlands Cancer InstituteHoffmann-La RocheNot yet recruiting
-
Helwan UniversityNot yet recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone-receptor-positive Breast Cancer
-
Nuvation Bio Inc.RecruitingPancreatic Cancer | Advanced Solid Tumor | HER2-negative Breast Cancer | Metastatic Castration-resistant Prostate Cancer (mCRPC) | Platinum-resistant Ovarian Cancer (PROC)United States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingAdvanced Breast Cancer | Metastatic Breast CancerChina
-
Enliven TherapeuticsRecruitingColorectal Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2 Amplification | HER2 Positive Solid TumorsUnited States
-
Boehringer IngelheimNot yet recruitingMetastatic Breast Cancer | Esophageal Adenocarcinoma | Metastatic Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma